The Patient-Reported Outcomes, Community-Engagement and Language (PRO-CEL) Core
- Institution
- SLOAN-KETTERING INST CAN RESEARCH, NY
- Principal investigator
- Thomas Michael Atkinson
- Funding
- $614K
- Duration
- 1997–2026
Moonbase score
Still being scored
Abstract
ABSTRACT The Patient-Reported Outcomes, Community Engagement, and Language (PRO-CEL) Core enhances the objectives of the Center's research programs by supporting the array of MSK investigators who wish to capture self-reported information from culturally varied patients, caregivers, clinical staff, and community members. The faculty of the PRO-CEL Core are nationally recognized social, behavioral sciences, and community engagement experts who provide technical assistance to all users throughout their various stages of research, including grant and protocol development, research study assistant and support staff training, and result dissemination. The PRO-CEL Core aims to 1) provide research consultation support and training in the selection and/or design of specific patient-reported outcome (PRO) survey tools, as well as measures to collect data from other key stakeholders (e.g., caregivers, physicians, nurses, community members at high risk of cancer); 2) assist investigators in the design, implementation and analysis of all aspects of qualitative research; 3) support MSK investigators who wish to incorporate PRO, qualitative and/ or community engagement research methods into peer-reviewed funding applications; and 4) provide methodological support for clinical trial, behavioral, and population-based research that seeks to engage community or understudied populations.
LOADING MOONBASE SCORE
Questions for SLOAN-KETTERING INST CAN RESEARCH
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Sloan-Kettering Inst Can Research60
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient
Jesse Joshua Smith · $80K · 2025
- NIH · Sloan-Kettering Inst Can Research51
Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)
Ping Chi · $576K · 2022–2026
- NIH · Sloan-Kettering Inst Can Research49
Targeting stem-like cells and their niche in pancreatic cancer
Tuomas Tammela · $491K · 2025–2026